Psilocybin and chronic neuropathic pain: a systematic review
Regional Anesthesia & Pain Medicine August 5, 2024 Harman Chopra, Shravani Durbhakula, Alexander Shustorovich et al. 8 citations
Background/Importance Chronic pain affects many people globally, requiring alternative management strategies. Psilocybin is gaining attention for its potential in chronic pain management despite being classified as Schedule I. Objective This systematic review critically evaluates the evidence for psilocybin, a Schedule I substance, in the treatment of chronic pain. The exact purpose of the...